CAVA Group’s blended fair value estimate now sits at about US$85.83 per share, compared with a prior figure of US$84, a modest 2.2% adjustment that has caught investors’ attention. This move comes as ...
The Herz P1 is positioned as a standalone fingertip pulse oximeter built for daily home monitoring. The company's marketing focuses on adults managing COPD, heart conditions, post-surgery recovery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results